AIVSX vs IWD: 33% overlap
American Funds Investment Company of America A and iShares Russell 1000 Value ETF share 33.4% of their portfolios by weight — computed as Σ min(wA, wB) over every holding both funds own.
Different holding dates. These holdings were published about 4 months apart — AIVSX as of 2026-03-31, the rest through 2026-07-23. Each fund is compared using its most recent file, so any trading in between shows up as a difference.
You would hold two tickers and get the diversification of 1.7. Two funds that shared nothing would score 2.0; two identical funds score 1.0.
Top shared holdings
AIVSX and IWD hold 106 of the same securities. The ten contributing most to the overlap figure:
| Holding | in AIVSX | in IWD | Δ |
|---|---|---|---|
| AMZN | 4.7% | 5.7% | 1.0% |
| MSFT | 5.7% | 3.9% | 1.7% |
| AAPL | 2.2% | 5.9% | 3.7% |
| ABBV | 1.1% | 1.2% | 0.1% |
| JPM | 1.1% | 2.6% | 1.5% |
| UNH | 1.0% | 1.1% | 0.0% |
| PM | 2.3% | 0.8% | 1.5% |
| RTX | 1.5% | 0.8% | 0.7% |
| CSCO | 0.7% | 1.2% | 0.5% |
| WFC | 1.1% | 0.7% | 0.4% |
Where AIVSX and IWD differ
Sector weights as a share of each fund, ordered by the size of the gap rather than the size of the sector — two funds that overlap heavily still usually diverge somewhere.
| Sector | AIVSX | IWD | Δ |
|---|---|---|---|
| Financials | 8.2% | 19.6% | −11.4pp |
| Information Technology | 29.2% | 18.0% | +11.1pp |
| Communication Services | 9.9% | 3.3% | +6.6pp |
| Unclassified | 5.5% | 0.0% | +5.5pp |
| Energy | 1.9% | 6.1% | −4.2pp |
| Real Estate | 0.8% | 3.7% | −2.9pp |
| Utilities | 2.3% | 3.9% | −1.7pp |
| Health Care | 11.2% | 12.7% | −1.5pp |
Δ is AIVSX minus IWD, in percentage points. Sector data is not published by every issuer, so “Unclassified” is a real category rather than a gap in the table.
What each fund holds alone
43.9% of AIVSX by weight, held in no part of IWD.
47.7% of IWD by weight, held in no part of AIVSX.
A large count with a small weight is the usual shape: the positions one fund adds are typically its smallest ones.
Concentration and cost
| AIVSX | IWD | |
|---|---|---|
| Top 10 holdings | 39.5% | 27.8% |
| Positions held | 168 | 872 |
| Cost per $10,000 held, per year | $58 | $19 |
Cost is the expense ratio applied to $10,000; it excludes any brokerage commission, bid-ask spread or tax consequence. Figures are facts about the funds, not a suggestion about which to hold.
Frequently asked
How much do AIVSX and IWD overlap?
AIVSX and IWD overlap 33.4% by portfolio weight — moderate overlap. They share 106 holdings. The figure comes from current issuer holdings files (AIVSX as of 2026-03-31, IWD as of 2026-07-23).
How is the overlap between AIVSX and IWD calculated?
As the sum of the smaller weight in each fund, over every holding both funds own: Σ min(wA, wB). If AIVSX holds a stock at 6% and IWD holds the same stock at 4%, 4% counts as shared. The result is bounded between 0% and 100%, and it is computed after looking through any fund-of-funds to the underlying holdings.
Is it redundant to hold both AIVSX and IWD?
That depends on your goals — we state facts, not advice. At 33.4% overlap, each fund still contributes meaningfully distinct exposure.
What does AIVSX own that IWD doesn't?
AIVSX holds 168 positions and IWD holds 872; 62 of AIVSX's positions don't appear in IWD at all, and they are 43.9% of AIVSX by weight.
You probably hold more than two funds
This page compares AIVSX and IWD. Paste your whole portfolio — brokerage, 401(k), IRA — and see the overlap across every fund at once, plus what you actually own underneath them and your own Effective Funds number. Free, no account, nothing stored.
X-ray my portfolio — free →Watch AIVSX vs IWD
We re-read both funds’ published holdings every weeknight. Leave an address and we'll tell you when what's inside actually changes.
Not sending yet — email alerts are built but switched off, and you'll be among the first when they turn on. No spam, one-click unsubscribe.
Related comparisons
Sources: issuer holdings files, AIVSX as of 2026-03-31, IWD as of 2026-07-23. Weights are fractions of each fund. Diagnostics, not advice.